130 related articles for article (PubMed ID: 33713943)
21. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
Yaskiv O; Zhang X; Simmerman K; Daly T; He H; Falzarano S; Chen L; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2011 Jul; 35(7):1062-8. PubMed ID: 21623182
[TBL] [Abstract][Full Text] [Related]
22. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
[TBL] [Abstract][Full Text] [Related]
23. MAGI2 is an independent predictor of biochemical recurrence in prostate cancer.
David SN; Arnold Egloff SA; Goyal R; Clark PE; Phillips S; Gellert LL; Hameed O; Giannico GA
Prostate; 2018 Jun; 78(8):616-622. PubMed ID: 29542165
[TBL] [Abstract][Full Text] [Related]
24. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical evaluation of ERG expression in various benign and malignant tissues.
Liu H; Shi J; Wilkerson M; Yang XJ; Lin F
Ann Clin Lab Sci; 2013; 43(1):3-9. PubMed ID: 23462600
[TBL] [Abstract][Full Text] [Related]
26. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate.
Willman JH; Holden JA
Prostate; 2000 Mar; 42(4):280-6. PubMed ID: 10679757
[TBL] [Abstract][Full Text] [Related]
28. ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.
Furusato B; Tan SH; Young D; Dobi A; Sun C; Mohamed AA; Thangapazham R; Chen Y; McMaster G; Sreenath T; Petrovics G; McLeod DG; Srivastava S; Sesterhenn IA
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):228-37. PubMed ID: 20585344
[TBL] [Abstract][Full Text] [Related]
29. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
31. Lack of ERG-antibody in Benign Mimickers of Prostate Cancer.
Bachurska SY; Staykov DG; Ivanov GP; Belovezhdov VT
Folia Med (Plovdiv); 2016 Mar; 58(1):48-53. PubMed ID: 27383878
[TBL] [Abstract][Full Text] [Related]
32. High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.
Obralic N; Kulovac B
Bosn J Basic Med Sci; 2011 Nov; 11(4):223-7. PubMed ID: 22117828
[TBL] [Abstract][Full Text] [Related]
33. Differential immunohistochemical expression of CD44s, E-cadherin and β-catenin among hyperplastic and neoplastic lesions of the prostate gland.
Lazari P; Poulias H; Gakiopoulou H; Thomopoulou GH; Barbatis C; Lazaris AC
Urol Int; 2013; 90(1):109-16. PubMed ID: 23220849
[TBL] [Abstract][Full Text] [Related]
34. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
35. Anti-glutamate receptor 2 as a new potential diagnostic probe for prostatic adenocarcinoma: a pilot immunohistochemical study.
Hechtman JF; Xiao GQ; Unger PD; Kinoshita Y; Godbold JH; Burstein DE
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):344-9. PubMed ID: 22417861
[TBL] [Abstract][Full Text] [Related]
36. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma.
Mazzucchelli R; Scarpelli M; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R
Cell Oncol (Dordr); 2013 Feb; 36(1):37-42. PubMed ID: 23132460
[TBL] [Abstract][Full Text] [Related]
38. The Significance of ERG and Androgen Receptor Expression in Adenocarcinoma Prostate.
Husain I; Sagar P; Shukla S; Babu S; Singhai A; Sankhwar SN; Husain N
Kathmandu Univ Med J (KUMJ); 2018 Oct.-Dec.; 16(64):277-280. PubMed ID: 31729338
[TBL] [Abstract][Full Text] [Related]
39. [Expression of nuclear Ki-67 antigen in prostatic high grade intraepithelial neoplasia and prostatic carcinoma].
Veliiković LJ; Dordević B; Rancić G; Marjanović G
Vojnosanit Pregl; 2007 May; 64(5):325-30. PubMed ID: 17585548
[TBL] [Abstract][Full Text] [Related]
40. ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance.
Hashmi AA; Khan EY; Irfan M; Ali R; Asif H; Naeem M; Nisar L; Faridi N; Khan A; Edhi MM
BMC Res Notes; 2019 Jan; 12(1):35. PubMed ID: 30658688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
